← Leaderboards
Jonathan Braun
Cedars-Sinai Medical Center
$5,381,905
Attributed
$5,571,105
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $789.8K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,571,105 · 9
By mechanism
P01$2,677,742 · 4
R01$1,316,384 · 1
R21$459,250 · 1
P30$434,543 · 1
R56$378,400 · 1
R03$304,786 · 1
Top collaborators
- Robert H Schiestl1 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Mitchell Kronenberg$46,508,740
- Stephan R. Targan$28,797,279
- Moshe Arditi$23,213,171
- David Q. Shih$754,650
- George Y Liu$11,032,137
Others in their field
Top investigators on “Inflammatory Bowel Diseases”
- Judy H Cho · University Of Chicago$48,459,647
- Ramnik J Xavier · Broad Institute, Inc.$43,517,622
- Mark J Daly · Broad Institute, Inc.$37,682,914
- Richard S Blumberg · Children'S Hospital Boston$36,446,455
- Stacey Gabriel · Massachusetts Institute Of Technology$34,637,180
- Eugene B Chang · University Of Chicago$28,912,342
Research focus
Inflammatory Bowel DiseasesBaseInflammationIn VivoT-LymphocyteAntibodiesImmunePhenotypeGeneticPredispositionChronicCellsEnvironmentCrohn&AposGenesCollaborationsSerumCell TypeResponseIn VitroImmunotherapyMolecularS DiseaseCd4 Positive T Lymphocytes
Grant awards (25)
Biomarking IBD patient-specific disease features using the epithelial antigenic peptidome$208,750
R21 · FY2021 · DK · contact PI
Biomarking IBD patient-specific disease features using the epithelial antigenic peptidome$250,500
R21 · FY2020 · DK · contact PI
The Functional Role and Genetic Control of Invariant HLA-E T Cells in IBD Risk an$401,435
P01 · FY2013 · DK · contact PI
Tumor Immunology$141,874
P30 · FY2013 · CA · contact PI
Mechanisms of Intestinal Inflammation - Associated Systemic Genotoxicity$378,400
R56 · FY2012 · AI
The Functional Role and Genetic Control of Invariant HLA-E T Cells in IBD Risk an$309,180
P01 · FY2012 · DK · contact PI
Tumor Immunology$102,211
P30 · FY2012 · CA · contact PI
Tumor Immunology$54,704
P30 · FY2011 · CA · contact PI
Regulatory B Cells in Mucosal Homeostasis and IBD$185,706
R01 · FY2010 · DK · contact PI
Tumor Immunology$69,664
P30 · FY2010 · CA · contact PI
B CELL IMMUNOREGULATION IN CROHN'S DISEASE$290,551
P01 · FY2009 · DK · contact PI
Tumor Immunology$66,090
P30 · FY2009 · CA · contact PI
B CELL IMMUNOREGULATION IN CROHN'S DISEASE$285,487
P01 · FY2008 · DK · contact PI
Regulatory B Cells in Mucosal Homeostasis and IBD$272,771
R01 · FY2008 · DK · contact PI
Regulatory B Cells in Mucosal Homeostasis and IBD$278,338
R01 · FY2007 · DK · contact PI
B CELL IMMUNOREGULATION IN CROHN'S DISEASE$222,306
P01 · FY2007 · DK · contact PI
Regulatory B Cells in Mucosal Homeostasis and IBD$286,652
R01 · FY2006 · DK · contact PI
B CELL IMMUNOREGULATION IN CROHN 'S DISEASE$235,524
P01 · FY2006 · DK · contact PI
Abnormal EMPS Expression Affects Pregnancy Outcome$150,869
R03 · FY2006 · HD · contact PI
Regulatory B Cells in Mucosal Homeostasis and IBD$292,917
R01 · FY2005 · DK
B CELL IMMUNOREGULATION IN CROHN 'S DISEASE$231,583
P01 · FY2005 · DK
Abnormal EMPS Expression Affects Pregnancy Outcome$153,917
R03 · FY2005 · HD
MICROBIAL ANTIGENS IN CROHN'S DISEASE$233,892
P01 · FY2002 · DK
MICROBIAL ANTIGENS IN CROHN'S DISEASE$233,892
P01 · FY2001 · DK
MICROBIAL ANTIGENS IN CROHN'S DISEASE$233,892
P01 · FY2000 · DK